PMDA drug package insert
ロラタジン錠10mg「フェルゼン」
PMDA Prescription drug · 株式会社フェルゼンファーマ · package insert May 23, 2024
Key facts
| Brand names | ロラタジン錠10mg「フェルゼン」, ロラタジンOD錠10mg「フェルゼン」 |
|---|---|
| Nonproprietary names | ロラタジン |
| Companies | 製造販売元／株式会社フェルゼンファーマ |
| Product type | Prescription drug |
| Therapeutic category | 持続性選択H1受容体拮抗・アレルギー性疾患治療剤 |
| Therapeutic category codes | 87449 |
| YJ codes | 4490027F1227, 4490027F2282 |
| Approval numbers | 22300AMX00832000, 22300AMX00833000 |
| Package insert edition | 第1版 |
| Package insert date | May 23, 2024 |
| PMDA document key | 671940_4490027F1227_1 |
| PMDA company code | 671940 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: